Founder at Quralis
Intro paths
→
In turn, Kasper can intro founders to Quralis's investors below.
Quralis's investors · 14
Amgen VenturesThousand Oaks · $1M – $3M checks · since 2023Dementia Discovery FundLondon · since 2023Dolby Family VenturesSan Francisco · since 2023Droia VenturesLeuven · $540K checks · since 2025EQT Life SciencesLuxembourg · $11M – $66M checks · since 2023InkefAmsterdam · since 2023MC Healthcare VenturesCambridgeMission Bay CapitalSan Francisco · since 2023Mission BiocapitalSan Francisco · $500K checks · since 2025Mitsui Global InvestmentMenlo Park · $500K – $10M checks · since 2023Polaris PartnersBoston · $500K – $5M checks · since 2025Sanofi VenturesCambridge · $5M checks · since 2023SV Health InvestorsBoston · $1M – $20M checksSynconaLondon · since 2022
Co-founders at Quralis
Experience
- QurAlisFounder and CEO of QurAliscurrent2017 — presentCambridge, US
- EnClear TherapiesBoard member and Scientific Advisory Board membercurrent2018 — presentMassachusetts, United States
- Harvard Medical School/ Boston Children's Hospital/ Harvard UniversityFellowcurrent2014 — presentGreater Boston
- Thrive Bioscience, Inc.Product Development Advisory Panel membercurrent2016 — present
- Harvard Stem Cell InstituteProject Alliance Manager2016 — 20177 Divinity Avenue, Cambridge
- Kasper Roet AdviesBusiness Owner2012 — 2014Amsterdam
- CrucellScientist and Team leader Molecular Bioassays and Functional technical integrator2012 — 2013Leiden
- The Netherlands Brain BankAutopsy team coordinator2008 — 2013
- Netherlands Institute for NeurosciencePhD project in Senternovem consortium project2006 — 2012
- University California San DiegoStudent project at the Center for Neural Repair2006
- Alex BeleggersbankService desk2005
- Institute for NeuroscienceStudent project at Dept. Neuroregeneration2004 — 2005
- NetfaseIT-entrepeneur2002 — 2005
- Nationale Postcode LoterijSupervisor telemarketing2001 — 2004
- Netherlands Cancer InstituteStudent project at Dept. Molecular Carcinogenesis2003
Skills & more
Molecular Biology26Neuroscience39Molecular Cloning2Product Development2Research Project Management3Systems AnalysisSales Presentations2Training Skills1People Management4Regenerative MedicineDrug Delivery1Fluorescence Microscopy1
+9 more
ImmunohistochemistryImmunocytochemistryAnimal ModelsHigh Throughput ScreeningCandidate SelectionCell CultureCell Based AssaysLife SciencesHealthcareLanguages Dutch
- PhD in Molecular Biology — United Latino Students Association
From Kasper's professional profile.
Frequently asked questions
- Who is Kasper Roet?
- Director, Executive Officer, Promoter at Quralis
- Where does Kasper Roet work?
- Kasper Roet is Founder of Quralis.
- What companies did Kasper Roet found?
- Kasper Roet founded Quralis.
- Where did Kasper Roet go to school?
- Kasper Roet studied at Graduate School Neurosciences Amsterdam and Rotterdam (PhD, Neuroscience); University of Amsterdam (MSc, Biomedical sciences focused on neuroscience).
Same school
Also attended University of Amsterdam282
Job van der VoortCo-founder & CEO of RemoteMartijn KleijwegtInvestor at LSP (Life Sciences Partners)René KuijtenInvestor at LSP (Life Sciences Partners)TorjusInvestor at InvestinorDamien van der BijlInvestment Director at Capricorn Venture PartnersAndrea van ElsasInvestor at Third Rock Ventures
+ 276 more
Shared employers
Also worked at QurAlis11
Johannes FruehaufGeneral Partner at Mission BiocapitalCaroline PinkneyInvestor at E12 Venture Capital, LlcSudhir AgrawalInvestor at 82VSMegInvestor at Sanofi VenturesJeffrey MoorePresident at MC Healthcare VenturesMiles GersonPartner at Dementia Discovery Fund
+ 5 more
Also worked at Harvard Medical School/ Boston Children's Hospital/ Harvard University58
Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Molly RobertsonOperations Associate at Founder CollectiveNasra MohamedInvestor at Third Rock VenturesJane SuhPrincipal on the AlleyCorp Healthcare teamJohn BrownsteinSenior Vice President and Chief Innovation Officer at Flare Capital PartnersBrian ButlerPartner at Questa Capital
+ 52 more
Also worked at Crucell11
Michel BriejerManaging Partner at Thuja CapitalHelmuth van EsAdvisory Committee member at Curie CapitalWouter VerhoevenVenture Partner at BioGeneration VenturesOscar SlotboomManaging Partner at BioGeneration VenturesRonald BrusFounder and Chief Growth Officer at Leyden LabsJean-Pierre MeijerFounder at Happyprinting
+ 5 more
